Literature DB >> 22654535

Management of pelvic heterotopic ossification post-myocutaneous flap reconstruction of a sacral pressure ulcer.

Colin W McInnes1, Richard Ak Reynolds, Jugpal S Arneja.   

Abstract

Heterotopic ossification (HO) is a process whereby lamellar bone forms in the soft tissues surrounding a joint. The most common type of HO is traumatic myositis ossificans, which develops following traumatic injuries, burns or arthroplasty. A variety of other forms of HO also exist, such as those associated with central nervous system injury and systemic forms that can manifest at other joints simultaneously. Clinically, patients can present with decreased range of motion, pressure ulcers, nerve compression, swelling, pain or asymptomatically. Symptomatic patients are most commonly treated with surgical debridement of the affected heterotopic deposits.Spinal dysraphism (SD) is a term describing a wide range of congenital malformations of the neural tube, ranging from spina bifida occulta to the more severe form, myelomeningocele. The cause of SD is multifactorial and has been associated with chromosomal disorders, teratogenic exposure and folate deficiency. Many patients with SD experience neuropathy below the affected neurological level, making them particularly susceptible to pressure ulcers. If these ulcers are severe and do not respond to conservative therapy, they often require surgical debridement and flap reconstruction - a clinical scenario that rarely results in HO.The present article describes a case involving a patient with pelvic HO following myocutaneous flap reconstruction of a pressure ulcer. The patient was successfully treated with oral bisphosphonate and aggressive physiotherapy.

Entities:  

Keywords:  Heterotopic ossification; Pressure ulcer; Reconstructive surgery

Year:  2011        PMID: 22654535      PMCID: PMC3328111     

Source DB:  PubMed          Journal:  Can J Plast Surg        ISSN: 1195-2199


  13 in total

1.  Radiation therapy for heterotopic ossification in a patient with traumatic brain injury.

Authors:  S H Jang; S W Shin; S H Ahn; I H Cho; S H Kim
Journal:  Yonsei Med J       Date:  2000-08       Impact factor: 2.759

Review 2.  Current therapy in the management of heterotopic ossification of the elbow: a review with case studies.

Authors:  B E Ellerin; D Helfet; S Parikh; R N Hotchkiss; N Levin; L Nisce; D Nori; J Moni
Journal:  Am J Phys Med Rehabil       Date:  1999 May-Jun       Impact factor: 2.159

Review 3.  Neurogenic heterotopic ossification in spinal cord injury.

Authors:  A A van Kuijk; A C H Geurts; H J M van Kuppevelt
Journal:  Spinal Cord       Date:  2002-07       Impact factor: 2.772

4.  Multifactorial refractory heterotopic ossification.

Authors:  Andrew J L Gear; Claire Buckley; Fred Kaplan; Alan Vanbeek
Journal:  Ann Plast Surg       Date:  2004-03       Impact factor: 1.539

Review 5.  Pharmacological interventions for treating acute heterotopic ossification.

Authors:  M Haran; T Bhuta; B Lee
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

6.  Preoperative embolization of heterotopic ossification for the treatment of a recalcitrant pressure sore.

Authors:  Eric A Appelt; Jeffrey M Kenkel; Joan R Ballard; Jorge A Lopez; Thomas Anthony; Teodoro Castillo
Journal:  Plast Reconstr Surg       Date:  2005-09-15       Impact factor: 4.730

7.  Radiation therapy for preventing recurrence of neurogenic heterotopic ossification.

Authors:  Cara Cipriano; Stephan G Pill; Jeffrey Rosenstock; Mary Ann Keenan
Journal:  Orthopedics       Date:  2009-09       Impact factor: 1.390

Review 8.  Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis.

Authors:  Patrick Vavken; Lorenzo Castellani; Thomas P Sculco
Journal:  Clin Orthop Relat Res       Date:  2009-06-11       Impact factor: 4.176

9.  Heterotopic ossification: treatment of established bone with radiation therapy.

Authors:  M A Schaeffer; J Sosner
Journal:  Arch Phys Med Rehabil       Date:  1995-03       Impact factor: 3.966

10.  Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. A comparison of doses of five hundred and fifty and seven hundred centigray.

Authors:  W L Healy; T C Lo; A A DeSimone; B Rask; B A Pfeifer
Journal:  J Bone Joint Surg Am       Date:  1995-04       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.